Harold H. Shlevin is Director at GALECTIN THERAPEUTICS INC (GALT). They have made 7 open-market trades across 1 company since 2013, most recently 2026-06-29.
CIK 0001557082
2 open-market purchases totalling $11K since 2013, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GALT | 6,500 | $24K |
Shares reported on the most recent Form 4, priced at the 2026-06-30 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GALT | SELL · 10b5-1 | 2026-06-26 | 2026-06-30 | $5.03 | $151K | -0.4% | -29.8% | -14.6% |
| GALT | SELL · 10b5-1 | 2025-12-17 | 2025-12-19 | $7.04 | $312K | -6.0% | -30.6% | -35.0% |
| GALT | SELL · 10b5-1 | 2025-12-12 | 2025-12-16 | $6.28 | $354K | -37.9% | -52.1% | -51.6% |
| GALT | SELL · 10b5-1 | 2025-12-08 | 2025-12-10 | $6.03 | $1.3M | -26.6% | -42.6% | -44.3% |
| GALT | BUY | 2024-12-30 | 2024-12-31 | $1.16 | $8K | -12.2% | -4.6% | -6.9% |
| GALT | SELL | 2018-06-12 | 2018-06-14 | $7.57 | $565K | -21.8% | -24.2% | -32.5% |
| GALT | SELL | 2018-06-08 | 2018-06-12 | $5.81 | $1.3M | +17.6% | +1.5% | -12.9% |
| GALT | SELL | 2018-06-06 | 2018-06-08 | $5.21 | $1.1M | +27.4% | +7.4% | -13.0% |
| GALT | SELL | 2018-06-04 | 2018-06-06 | $5.15 | $215K | +80.0% | +32.4% | +28.5% |
| GALT | SELL | 2018-05-31 | 2018-06-04 | $5.06 | $603K | +62.2% | +37.8% | +30.0% |
| GALT | BUY | 2013-11-18 | 2013-11-19 | $6.63 | $3K | -20.0% | +1.3% | +1.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.